Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2012
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
09/2012
09/30/2012CA2828097A1 Capacitance detection in electrochemical assay with improved sampling time offset
09/27/2012WO2012129558A1 Use of genetic testing of patient biopsy specimens to confirm patient identification
09/27/2012WO2012129488A2 Gene signatures associated with rejection or recurrence of cancer
09/27/2012WO2012129457A2 Diagnostic and treatment methods using a ligand library
09/27/2012WO2012129455A2 Microfluidic devices and methods of manufacture and use
09/27/2012WO2012129452A2 Propynoic acid carbamoyl methyl-almides and pharmaceutical compositions and methods based thereon
09/27/2012WO2012129444A2 Rapid tests for the detection of inhibitors of enzymes and human exposure to the same
09/27/2012WO2012129423A2 Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
09/27/2012WO2012129412A1 Method for assembly of analyte filter arrays using biomolecules
09/27/2012WO2012129408A2 Biomarkers for aggressive prostate cancer
09/27/2012WO2012129399A2 Compositions for and methods of evaluating tumors having a skeletal muscle origin
09/27/2012WO2012129393A1 Assay for screening compounds that selectively decrease the number of cancer stem cells
09/27/2012WO2012129347A1 Classification of kinase inhibitors using nonlinear optical techniques
09/27/2012WO2012129341A2 Disease detection in plants
09/27/2012WO2012129325A1 Molecular analysis of tumor samples
09/27/2012WO2012129312A2 Methods and systems for multiple control validation
09/27/2012WO2012129246A2 Method for predicting severity of allergic reaction
09/27/2012WO2012129242A2 Isolation of polymerase-nucleic acid complexes and loading onto substrates
09/27/2012WO2012129237A2 Therapeutic agent for emphysema and copd
09/27/2012WO2012129164A2 Biosensor
09/27/2012WO2012129150A2 Metal-enhanced photoluminescence from carbon nanodots
09/27/2012WO2012129128A1 Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules
09/27/2012WO2012129082A1 Treatments targeting gamma-synuclein expression levels
09/27/2012WO2012129068A1 Optical sensing device for sensing analytes and related apparatus and methods
09/27/2012WO2012129048A2 Methods to predict sperm retrieval in males
09/27/2012WO2012129008A1 Line-1 hypomethylation as a biomarker for early-onset colorectal cancer
09/27/2012WO2012128904A1 Long interspersed nuclear elements (line-1) and alu hypomethylation as biomarkers for colorectal cancer metastasis
09/27/2012WO2012128841A2 Micro-devices for disease detection
09/27/2012WO2012128810A1 Methods and systems for the analysis of protein samples
09/27/2012WO2012128764A1 Apparatus and methods for lithlogy and mineralogy determinations
09/27/2012WO2012128762A1 Hybrid nanostructures for molecular analysis
09/27/2012WO2012128658A1 Method for producing a panel of sera with hbsag subtypes ad and ay for quality control in hepatitis в diagnostics
09/27/2012WO2012128633A1 Improved prediction of cardiovascular and metabolic disease development
09/27/2012WO2012128616A1 A method of analysing a blood sample of a subject for the presence of a disease marker
09/27/2012WO2012128577A2 Method for performance analysis and screening of septicaemia protein therapeutic agents
09/27/2012WO2012128377A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012WO2012128345A1 Specimen analysis device, specimen information processing device, and specimen analysis method
09/27/2012WO2012128338A1 Method and kit for super-high-sensitivity measurement of protein and nucleic acid, and novel enzyme substrate
09/27/2012WO2012128143A1 Monoclonal antibody specific to west nile viral structural protein and method for determining west nile viral infection using monoclonal antibody
09/27/2012WO2012128108A1 Asbestos exposure history marker and use therefor
09/27/2012WO2012127984A1 Marker for determination of sensitivity to anticancer agent
09/27/2012WO2012127871A1 Combination medicine for treatment of depression
09/27/2012WO2012127870A1 Living organism information measurement device
09/27/2012WO2012127794A1 Nitrogen oxide concentration measurement device
09/27/2012WO2012127473A1 Method and kit for estimating human immunodeficiency virus (hiv) incidence
09/27/2012WO2012127422A1 Device for the extracorporeal monitoring of blood
09/27/2012WO2012127412A1 Preparation of food controlled by a taste sensor
09/27/2012WO2012127314A1 Method and device for determining the internal integrity of a changing composite medium
09/27/2012WO2012127264A1 Method and installation for testing a chemical composition including at least brine and a surfactant, in particular an eor composition
09/27/2012WO2012127240A2 Immune assay
09/27/2012WO2012127213A1 Biomarkers
09/27/2012WO2012127181A1 A method and apparatus for washing rock samples
09/27/2012WO2012127130A1 Method for quickly characterizing and quantifying the carbonates of a solid material
09/27/2012WO2012127124A1 Tests dedicated to oncology and to neuro-oncology
09/27/2012WO2012127122A1 Method for performing a rapid test
09/27/2012WO2012127062A1 Dominant negative hsp110 mutant and its use in prognosing and treating cancers
09/27/2012WO2012127060A1 Peptides capable of forming a covalent complex, and uses thereof
09/27/2012WO2012127050A2 Device and method for filtering blood
09/27/2012WO2012127041A1 Method of screening antiretroviral compounds and vaccine
09/27/2012WO2012127034A1 Device and method for removing a supernatant of a liquid sample, and use of a valve device having a soluble membrane
09/27/2012WO2012126940A1 Immune suppressor and its use
09/27/2012WO2012126933A1 Diagnostic marker for relapsing primary idiopathic focal segmental glomerulosclerosis
09/27/2012WO2012126882A1 Identification of antiobiotic resistance
09/27/2012WO2012126873A1 Method for detecting and quantifying a target molecule in a sample
09/27/2012WO2012126802A1 Diamond based electrochemical sensors
09/27/2012WO2012126793A1 Whole proteome tiling microarrays
09/27/2012WO2012126531A1 Method for diagnosing acute coronary syndrome (acs)
09/27/2012WO2012126294A1 Biological chip hybridization system
09/27/2012WO2012126293A1 Automatic injection device for microarray chip and automatic injection hybridization microarray chip
09/27/2012WO2012126172A1 Peptides inhibiting adhesion of aspergillus fumigatus to cornea
09/27/2012WO2012126152A1 Heat-shrinkable combined microchannel chip, preparation, and use method
09/27/2012WO2012126118A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012WO2012106407A3 Diagnostic and therapeutic methods and products related to anxiety disorders
09/27/2012WO2012081856A9 Method for preparing nucleic acid probe-coated porous solid support strip
09/27/2012WO2012078925A3 Apparatus and method for implementing hydroclone based fluid filtration systems with extensible isolated filter stages
09/27/2012WO2012078863A3 Sample analysis system
09/27/2012WO2012076614A3 Apparatus and method for the collection of samples of exhaled air
09/27/2012WO2012075501A3 Diagnosing and grading acute lymphocytic leukemia
09/27/2012WO2012075313A3 Ph modulation methods and systems for detecting binding events
09/27/2012WO2012075258A3 Ratiometric immunoassay method and blood testing device
09/27/2012WO2012074973A3 Electrophoresis gel system
09/27/2012WO2012074550A3 Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling
09/27/2012WO2012071461A3 Method of making and using fluorescent-tagged nanoparticles and microarrays
09/27/2012WO2012070893A3 Single nanoparticle having a nanogap between a core material and a shell material, and manufacturing method thereof
09/27/2012WO2012068511A3 Method for amplification-free nucleic acid detection on optofluidic chips
09/27/2012WO2012068392A3 Low cost, portable sensor for molecular assays
09/27/2012WO2012068288A3 Diagnosing and monitoring cns malignancies using microrna
09/27/2012WO2012065178A3 Albumin-bound protein/peptide complex as a biomarker for disease
09/27/2012WO2012064880A3 Urinary porphyrins as biomarkers of autistic spectrum disorder risk
09/27/2012WO2012061797A4 On-chip 4d lightfield microscope
09/27/2012WO2012050881A3 Molecular delivery with nanowires
09/27/2012WO2012018982A3 Methods and kits for modulating tumor invasiveness and metastatic potential
09/27/2012WO2012015200A3 Composition for diagnosing, treating, and preventing liver disease
09/27/2012WO2011089293A9 Histological method optimised for the preservation of antigenic epitopes and the cellular architecture of tissues from vertebrates
09/27/2012US20120246757 Modulation of cellular protein function by artificial sumo ligases
09/27/2012US20120246745 Methods for Screening for Agents that Affect Development
09/27/2012US20120245856 Characterization of molecules
09/27/2012US20120245334 Methods of using fet labeled oligonucleotides that include a 3'-5' exonuclease resistant quencher domain and compositions for practicing the same
09/27/2012US20120245235 Classification of cancers